We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.

Annual medicines planning

Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Biosimilars Updates

Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab and tocilizumab biosimilars.